SATELLOS BIOSCIENCE INC (MSCL.CA) Stock News

TSX-V:MSCL - TSX Venture Exchange - CA45107J1057 - Common Stock - Currency: CAD

0.57 0 (0%)

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

MSCL.CA Latest News, Press Relases and Analysis

All

Press Releases

1 years ago - By: Satellos Bioscience Inc. - Mentions: TSX

Satellos Announces Promising Preliminary Data in Facioscapulohumeral Muscular Dystrophy

2 years ago - By: Satellos Bioscience Inc. - Mentions: TSX

Satellos Receives Conditional Approval to Graduate to the Toronto Stock Exchange

2 years ago - By: Satellos Bioscience Inc. - Mentions: TSX

Satellos Bioscience Announces 2023 Q3 Financial Results and Operational Highlights

2 years ago - By: Satellos Bioscience Inc. - Mentions: TSX

Satellos to Present at the Piper Sandler 35th Annual Healthcare Conference

2 years ago - By: Satellos Bioscience Inc. - Mentions: TSX

Satellos Discloses Drug Target and Provides Development Update on Duchenne Muscular Dystrophy Program

2 years ago - By: Satellos Bioscience Inc. - Mentions: TSX

Satellos to Present at the Stifel 2023 Healthcare Conference

4 years ago - By: TSX Venture Exchange

Satellos Virtually Opens the Market

4 years ago - By: Investment Industry Regulatory Organization of Canada (IIROC) - Halts/Resumptions

IIROC Trading Resumption - MSCL